HLN

Haleon plc

Healthcare›Drug Manufacturers - Specialty & Generic|New York Stock Exchange|GB

Price

$9.93

Market Cap

$44.27B

Beta

0.25

P/E

16.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+13.67%

EPS Growth (YoY)+40.55%

Revenue CAGR 3Y+0.00%

P/E Ratio16.0

PEG Ratio0.40

FCF Yield+5.17%

Debt / Equity0.52

Interest Coverage8.3x

No credit card required

Already have an account? Sign in to view the full analysis for HLN.